z-logo
open-access-imgOpen Access
Neurodevelopmental delay in the Cln3 Δex7/8 mouse model for Batten disease
Author(s) -
Osório N. S.,
SampaioMarques B.,
Chan C.H.,
Oliveira P.,
Pearce D. A.,
Sousa N.,
Rodrigues F.
Publication year - 2009
Publication title -
genes, brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 91
eISSN - 1601-183X
pISSN - 1601-1848
DOI - 10.1111/j.1601-183x.2009.00478.x
Subject(s) - batten disease , neuronal ceroid lipofuscinosis , disease , neuroscience , dystonia , medicine , psychology
Juvenile neuronal ceroid lipofuscinosis (JNCL), also known as Batten disease, is a fatal inherited neurodegenerative disorder. The major clinical features of this disease are vision loss, seizures and progressive cognitive and motor decline starting in childhood. Mutations in CLN3 are known to cause the disease, allowing the generation of mouse models that are powerful tools for JNCL research. In this study, we applied behavioural phenotyping protocols to test for early behavioural alterations in Cln3 Δex7/8 knock‐in mice, a genetic model that harbours the most common disease‐causing CLN3 mutation. We found delayed acquisition of developmental milestones, including negative geotaxis, grasping, wire suspension time and postural reflex in both homozygous and heterozygous Cln3 Δex7/8 preweaning pups. To further investigate the consequences of this neurodevelopmental delay, we studied the behaviour of juvenile mice and found that homozygous and heterozygous Cln3 Δex7/8 knock‐in mice also exhibit deficits in exploratory activity. Moreover, when analysing motor behaviour, we observed severe motor deficits in Cln3 Δex7/8 homozygous mice, but only a mild impairment in motor co‐ordination and ambulatory gait in Cln3 Δex7/8 heterozygous animals. This study reveals previously overlooked behaviour deficits in neonate and young adult Cln3 Δex7/8 mice indicating neurodevelopmental delay as a putative novel component of JNCL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here